Logo

Sistemic

Sistemic, RoosterBio Collaborate on MSC Regenerative Technology

The firms will use miRNA-based cell characterization workflows and technologies to develop panels for human MSC products and cell banks.

Sistemic, NHS Scotland Developing Biomarkers for Diabetes-related Sight Loss

NEW YORK (GenomeWeb News) – Sistemic today announced an agreement with NHS Scotland to develop biomarkers for the early detection of diabetic retinopathy and infective keratitis. Financial and other terms of the deal were not disclosed.

Progenitor Cell Therapy to Evaluate Sistemic Technology
Premium

Sistemic, a microRNA profiling firm, said this week that it has signed a deal under which NeoStem subsidiary Progenitor Cell Therapy will evaluate its stem cell-characterization technology.

EMD Millipore, Sistemic Developing Stem Cell Technology

NEW YORK (GenomeWeb News) – EMD Millipore today said it is jointly developing a microRNA biomarker-based monitoring methodology with Sistemic for the consistent growth of stem cells in EMD Millipore's Mobius CellReady platform.

Sistemic Lands Scottish Economic Development Funding

NEW YORK (GenomeWeb News) – Sistemic, an miRNA-based products developer, said today that it has received an undisclosed amount of funding from the economic development entity Scottish Enterprise.
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.